The global market for Budesonide was estimated to be worth US$ 8203 million in 2023 and is forecast to a readjusted size of US$ 10250 million by 2030 with a CAGR of 3.2% during the forecast period 2024-2030

Budesonide - Market

Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.

North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.

The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Budesonide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Budesonide by region & country, by Type, and by Application.

The Budesonide market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide.

Market Segmentation

Scope of Budesonide - Market Report

Report Metric	Details
Report Name	Budesonide - Market
Forecasted market size in 2030	US$ 10250 million
CAGR	3.2%
Forecasted years	2024 - 2030
Segment by Type:	Injectable Suspension Aerosols Inhalation Powder Tablet and Capsule
Segment by Application	Respiratory Disease Treatment Nose Disease Treatment Inflammatory Bowel Disease Treatment Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Budesonide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Budesonide - Market size in 2030?

Ans: The Budesonide - Market size in 2030 will be US$ 10250 million.

What is the AstraZeneca share in Budesonide - Market?

Ans: AstraZeneca is the largest manufacturer with about 56% revenue market share.

Who are the main players in the Budesonide - Market report?

Ans: The main players in the Budesonide - Market are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod

What are the Application segmentation covered in the Budesonide - Market report?

Ans: The Applications covered in the Budesonide - Market report are Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Others

What are the Type segmentation covered in the Budesonide - Market report?

Ans: The Types covered in the Budesonide - Market report are Injectable Suspension, Aerosols, Inhalation Powder, Tablet and Capsule

1 Market Overview

1.1 Budesonide Product Introduction

1.2 Global Budesonide Market Size Forecast

1.2.1 Global Budesonide Sales Value (2019-2030)

1.2.2 Global Budesonide Sales Volume (2019-2030)

1.2.3 Global Budesonide Sales Price (2019-2030)

1.3 Budesonide Market Trends & Drivers

1.3.1 Budesonide Industry Trends

1.3.2 Budesonide Market Drivers & Opportunity

1.3.3 Budesonide Market Challenges

1.3.4 Budesonide Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Budesonide Players Revenue Ranking (2023)

2.2 Global Budesonide Revenue by Company (2019-2024)

2.3 Global Budesonide Players Sales Volume Ranking (2023)

2.4 Global Budesonide Sales Volume by Company Players (2019-2024)

2.5 Global Budesonide Average Price by Company (2019-2024)

2.6 Key Manufacturers Budesonide Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Budesonide Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Budesonide

2.9 Budesonide Market Competitive Analysis

2.9.1 Budesonide Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Budesonide Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Injectable Suspension

3.1.2 Aerosols

3.1.3 Inhalation Powder

3.1.4 Tablet and Capsule

3.2 Global Budesonide Sales Value by Type

3.2.1 Global Budesonide Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Budesonide Sales Value, by Type (2019-2030)

3.2.3 Global Budesonide Sales Value, by Type (%) (2019-2030)

3.3 Global Budesonide Sales Volume by Type

3.3.1 Global Budesonide Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Budesonide Sales Volume, by Type (2019-2030)

3.3.3 Global Budesonide Sales Volume, by Type (%) (2019-2030)

3.4 Global Budesonide Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Respiratory Disease Treatment

4.1.2 Nose Disease Treatment

4.1.3 Inflammatory Bowel Disease Treatment

4.1.4 Others

4.2 Global Budesonide Sales Value by Application

4.2.1 Global Budesonide Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Budesonide Sales Value, by Application (2019-2030)

4.2.3 Global Budesonide Sales Value, by Application (%) (2019-2030)

4.3 Global Budesonide Sales Volume by Application

4.3.1 Global Budesonide Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Budesonide Sales Volume, by Application (2019-2030)

4.3.3 Global Budesonide Sales Volume, by Application (%) (2019-2030)

4.4 Global Budesonide Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Budesonide Sales Value by Region

5.1.1 Global Budesonide Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Budesonide Sales Value by Region (2019-2024)

5.1.3 Global Budesonide Sales Value by Region (2025-2030)

5.1.4 Global Budesonide Sales Value by Region (%), (2019-2030)

5.2 Global Budesonide Sales Volume by Region

5.2.1 Global Budesonide Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Budesonide Sales Volume by Region (2019-2024)

5.2.3 Global Budesonide Sales Volume by Region (2025-2030)

5.2.4 Global Budesonide Sales Volume by Region (%), (2019-2030)

5.3 Global Budesonide Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Budesonide Sales Value, 2019-2030

5.4.2 North America Budesonide Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Budesonide Sales Value, 2019-2030

5.5.2 Europe Budesonide Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Budesonide Sales Value, 2019-2030

5.6.2 Asia Pacific Budesonide Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Budesonide Sales Value, 2019-2030

5.7.2 South America Budesonide Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Budesonide Sales Value, 2019-2030

5.8.2 Middle East & Africa Budesonide Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Budesonide Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Budesonide Sales Value

6.2.1 Key Countries/Regions Budesonide Sales Value, 2019-2030

6.2.2 Key Countries/Regions Budesonide Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Budesonide Sales Value, 2019-2030

6.3.2 United States Budesonide Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Budesonide Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Budesonide Sales Value, 2019-2030

6.4.2 Europe Budesonide Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Budesonide Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Budesonide Sales Value, 2019-2030

6.5.2 China Budesonide Sales Value by Type (%), 2023 VS 2030

6.5.3 China Budesonide Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Budesonide Sales Value, 2019-2030

6.6.2 Japan Budesonide Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Budesonide Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Budesonide Sales Value, 2019-2030

6.7.2 South Korea Budesonide Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Budesonide Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Budesonide Sales Value, 2019-2030

6.8.2 Southeast Asia Budesonide Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Budesonide Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Budesonide Sales Value, 2019-2030

6.9.2 India Budesonide Sales Value by Type (%), 2023 VS 2030

6.9.3 India Budesonide Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AstraZeneca

7.1.1 AstraZeneca Company Information

7.1.2 AstraZeneca Introduction and Business Overview

7.1.3 AstraZeneca Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AstraZeneca Budesonide Product Offerings

7.1.5 AstraZeneca Recent Development

7.2 Teva

7.2.1 Teva Company Information

7.2.2 Teva Introduction and Business Overview

7.2.3 Teva Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Teva Budesonide Product Offerings

7.2.5 Teva Recent Development

7.3 Mylan

7.3.1 Mylan Company Information

7.3.2 Mylan Introduction and Business Overview

7.3.3 Mylan Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Mylan Budesonide Product Offerings

7.3.5 Mylan Recent Development

7.4 Sandoz

7.4.1 Sandoz Company Information

7.4.2 Sandoz Introduction and Business Overview

7.4.3 Sandoz Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sandoz Budesonide Product Offerings

7.4.5 Sandoz Recent Development

7.5 Cosmo Pharmaceuticals

7.5.1 Cosmo Pharmaceuticals Company Information

7.5.2 Cosmo Pharmaceuticals Introduction and Business Overview

7.5.3 Cosmo Pharmaceuticals Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Cosmo Pharmaceuticals Budesonide Product Offerings

7.5.5 Cosmo Pharmaceuticals Recent Development

7.6 Salix

7.6.1 Salix Company Information

7.6.2 Salix Introduction and Business Overview

7.6.3 Salix Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Salix Budesonide Product Offerings

7.6.5 Salix Recent Development

7.7 Chiesi Farmaceutici

7.7.1 Chiesi Farmaceutici Company Information

7.7.2 Chiesi Farmaceutici Introduction and Business Overview

7.7.3 Chiesi Farmaceutici Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Chiesi Farmaceutici Budesonide Product Offerings

7.7.5 Chiesi Farmaceutici Recent Development

7.8 Orion Corporation

7.8.1 Orion Corporation Company Information

7.8.2 Orion Corporation Introduction and Business Overview

7.8.3 Orion Corporation Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Orion Corporation Budesonide Product Offerings

7.8.5 Orion Corporation Recent Development

7.9 Cipla

7.9.1 Cipla Company Information

7.9.2 Cipla Introduction and Business Overview

7.9.3 Cipla Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Cipla Budesonide Product Offerings

7.9.5 Cipla Recent Development

7.10 Synmosa Biopharma

7.10.1 Synmosa Biopharma Company Information

7.10.2 Synmosa Biopharma Introduction and Business Overview

7.10.3 Synmosa Biopharma Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Synmosa Biopharma Budesonide Product Offerings

7.10.5 Synmosa Biopharma Recent Development

7.11 Lunan Better Pharma

7.11.1 Lunan Better Pharma Company Information

7.11.2 Lunan Better Pharma Introduction and Business Overview

7.11.3 Lunan Better Pharma Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Lunan Better Pharma Budesonide Product Offerings

7.11.5 Lunan Better Pharma Recent Development

7.12 Shanghai Sine Promod

7.12.1 Shanghai Sine Promod Company Information

7.12.2 Shanghai Sine Promod Introduction and Business Overview

7.12.3 Shanghai Sine Promod Budesonide Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Shanghai Sine Promod Budesonide Product Offerings

7.12.5 Shanghai Sine Promod Recent Development

8 Industry Chain Analysis

8.1 Budesonide Industrial Chain

8.2 Budesonide Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Budesonide Sales Model

8.5.2 Sales Channel

8.5.3 Budesonide Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Cosmo Pharmaceuticals

List of Tables

Table 1. Budesonide Market Trends

Table 2. Budesonide Market Drivers & Opportunity

Table 3. Budesonide Market Challenges

Table 4. Budesonide Market Restraints

Table 5. Global Budesonide Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Budesonide Revenue Market Share by Company (2019-2024)

Table 7. Global Budesonide Sales Volume by Company (2019-2024) & (M Units)

Table 8. Global Budesonide Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Budesonide Price by Company (2019-2024) & (USD/K Units)

Table 10. Key Manufacturers Budesonide Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Budesonide Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Budesonide

Table 13. Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Budesonide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Budesonide Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Budesonide Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Budesonide Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Budesonide Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Budesonide Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)

Table 22. Global Budesonide Sales Volume by Type (2019-2024) & (M Units)

Table 23. Global Budesonide Sales Volume by Type (2025-2030) & (M Units)

Table 24. Global Budesonide Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Budesonide Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Budesonide Price by Type (2019-2024) & (USD/K Units)

Table 27. Global Budesonide Price by Type (2025-2030) & (USD/K Units)

Table 28. Global Budesonide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Budesonide Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Budesonide Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Budesonide Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Budesonide Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Budesonide Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)

Table 34. Global Budesonide Sales Volume by Application (2019-2024) & (M Units)

Table 35. Global Budesonide Sales Volume by Application (2025-2030) & (M Units)

Table 36. Global Budesonide Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Budesonide Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Budesonide Price by Application (2019-2024) & (USD/K Units)

Table 39. Global Budesonide Price by Application (2025-2030) & (USD/K Units)

Table 40. Global Budesonide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Budesonide Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Budesonide Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Budesonide Sales Value by Region (2019-2024) & (%)

Table 44. Global Budesonide Sales Value by Region (2025-2030) & (%)

Table 45. Global Budesonide Sales Volume by Region (M Units): 2019 VS 2023 VS 2030

Table 46. Global Budesonide Sales Volume by Region (2019-2024) & (M Units)

Table 47. Global Budesonide Sales Volume by Region (2025-2030) & (M Units)

Table 48. Global Budesonide Sales Volume by Region (2019-2024) & (%)

Table 49. Global Budesonide Sales Volume by Region (2025-2030) & (%)

Table 50. Global Budesonide Average Price by Region (2019-2024) & (USD/K Units)

Table 51. Global Budesonide Average Price by Region (2025-2030) & (USD/K Units)

Table 52. Key Countries/Regions Budesonide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Budesonide Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Budesonide Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Budesonide Sales Volume, (2019-2024) & (M Units)

Table 56. Key Countries/Regions Budesonide Sales Volume, (2025-2030) & (M Units)

Table 57. AstraZeneca Company Information

Table 58. AstraZeneca Introduction and Business Overview

Table 59. AstraZeneca Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 60. AstraZeneca Budesonide Product Offerings

Table 61. AstraZeneca Recent Development

Table 62. Teva Company Information

Table 63. Teva Introduction and Business Overview

Table 64. Teva Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 65. Teva Budesonide Product Offerings

Table 66. Teva Recent Development

Table 67. Mylan Company Information

Table 68. Mylan Introduction and Business Overview

Table 69. Mylan Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 70. Mylan Budesonide Product Offerings

Table 71. Mylan Recent Development

Table 72. Sandoz Company Information

Table 73. Sandoz Introduction and Business Overview

Table 74. Sandoz Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 75. Sandoz Budesonide Product Offerings

Table 76. Sandoz Recent Development

Table 77. Cosmo Pharmaceuticals Company Information

Table 78. Cosmo Pharmaceuticals Introduction and Business Overview

Table 79. Cosmo Pharmaceuticals Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 80. Cosmo Pharmaceuticals Budesonide Product Offerings

Table 81. Cosmo Pharmaceuticals Recent Development

Table 82. Salix Company Information

Table 83. Salix Introduction and Business Overview

Table 84. Salix Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 85. Salix Budesonide Product Offerings

Table 86. Salix Recent Development

Table 87. Chiesi Farmaceutici Company Information

Table 88. Chiesi Farmaceutici Introduction and Business Overview

Table 89. Chiesi Farmaceutici Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 90. Chiesi Farmaceutici Budesonide Product Offerings

Table 91. Chiesi Farmaceutici Recent Development

Table 92. Orion Corporation Company Information

Table 93. Orion Corporation Introduction and Business Overview

Table 94. Orion Corporation Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 95. Orion Corporation Budesonide Product Offerings

Table 96. Orion Corporation Recent Development

Table 97. Cipla Company Information

Table 98. Cipla Introduction and Business Overview

Table 99. Cipla Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 100. Cipla Budesonide Product Offerings

Table 101. Cipla Recent Development

Table 102. Synmosa Biopharma Company Information

Table 103. Synmosa Biopharma Introduction and Business Overview

Table 104. Synmosa Biopharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 105. Synmosa Biopharma Budesonide Product Offerings

Table 106. Synmosa Biopharma Recent Development

Table 107. Lunan Better Pharma Company Information

Table 108. Lunan Better Pharma Introduction and Business Overview

Table 109. Lunan Better Pharma Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 110. Lunan Better Pharma Budesonide Product Offerings

Table 111. Lunan Better Pharma Recent Development

Table 112. Shanghai Sine Promod Company Information

Table 113. Shanghai Sine Promod Introduction and Business Overview

Table 114. Shanghai Sine Promod Budesonide Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2019-2024)

Table 115. Shanghai Sine Promod Budesonide Product Offerings

Table 116. Shanghai Sine Promod Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Budesonide Downstream Customers

Table 120. Budesonide Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Budesonide Product Picture

Figure 2. Global Budesonide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Budesonide Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Budesonide Sales Volume (2019-2030) & (M Units)

Figure 5. Global Budesonide Sales Price (2019-2030) & (USD/K Units)

Figure 6. Budesonide Report Years Considered

Figure 7. Global Budesonide Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Budesonide Players Sales Volume Ranking (2023) & (M Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Budesonide Revenue in 2023

Figure 10. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Injectable Suspension Picture

Figure 12. Aerosols Picture

Figure 13. Inhalation Powder Picture

Figure 14. Tablet and Capsule Picture

Figure 15. Global Budesonide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Budesonide Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Budesonide Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)

Figure 18. Global Budesonide Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Budesonide Price by Type (2019-2030) & (USD/K Units)

Figure 20. Product Picture of Respiratory Disease Treatment

Figure 21. Product Picture of Nose Disease Treatment

Figure 22. Product Picture of Inflammatory Bowel Disease Treatment

Figure 23. Product Picture of Others

Figure 24. Global Budesonide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Budesonide Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Budesonide Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)

Figure 27. Global Budesonide Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Budesonide Price by Application (2019-2030) & (USD/K Units)

Figure 29. North America Budesonide Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Budesonide Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Budesonide Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Budesonide Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Budesonide Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Budesonide Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Budesonide Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Budesonide Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Budesonide Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Budesonide Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Budesonide Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Budesonide Sales Volume (%), (2019-2030)

Figure 41. United States Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 47. China Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 49. China Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 59. India Budesonide Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Budesonide Sales Value by Type (%), 2023 VS 2030

Figure 61. India Budesonide Sales Value by Application (%), 2023 VS 2030

Figure 62. Budesonide Industrial Chain

Figure 63. Budesonide Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-32D13978

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Fluoxetine Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-2J14387

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Global Autoimmune Disorder Drug Delivery Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0K8018

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Metronidazole API Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18R12687

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Budesonide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: March 2024

Report Code: QYRE-Auto-18T594

Budesonide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Budesonide - Market Size

Budesonide - Market

Report Scope

Scope of Budesonide - Market Report

Chapter Outline

FAQ for this report

What is the Budesonide - Market size in 2030?

What is the AstraZeneca share in Budesonide - Market?

Who are the main players in the Budesonide - Market report?

What are the Application segmentation covered in the Budesonide - Market report?

What are the Type segmentation covered in the Budesonide - Market report?

FEATURED COMPANIES

RELATED REPORTS